ABCG2 and glioblastoma: OCT3/4 has been confirmed to be involved in the chemotherapy resistance of glioblastoma cell lines by affecting the expression of the drug efflux pump gene ABCG2, which encodes breast cancer resistance protein (BCRP) [61].